Literature DB >> 16536901

Effects of tamsulosin on resting urethral pressure and arterial blood pressure in anaesthetized female dogs.

Akiyoshi Ohtake1, Shuichi Sato, Masao Sasamata, Keiji Miyata.   

Abstract

The purposes of the present study were to investigate the effects of the alpha1-adrenoceptor antagonists tamsulosin, prazosin and urapidil on resting urethral pressure in anaesthetized female dogs, and to compare the results with their effects on arterial blood pressure. Tamsulosin decreased resting maximal urethral pressure in the urethral pressure profile in a dose-dependent fashion, whereas it had almost no effect on mean arterial blood pressure. Prazosin and urapidil also dose-dependently decreased resting maximal urethral pressure, but these effects were accompanied by decreases in mean arterial blood pressure. Thus, of these three compounds, tamsulosin dose-dependently decreased resting maximal urethral pressure with negligible effect on mean arterial blood pressure in female dogs. These results suggest that tamsulosin will be useful in the treatment of voiding dysfunction associated with bladder outlet obstruction in women, with little hypotensive effect.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16536901     DOI: 10.1211/jpp.58.3.0008

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  2 in total

1.  Alpha1A-adrenoceptor antagonist improves underactive bladder associated with diabetic cystopathy via bladder blood flow in rats.

Authors:  Saori Yonekubo; Satoshi Tatemichi; Kazuyasu Maruyama; Mamoru Kobayashi
Journal:  BMC Urol       Date:  2017-08-23       Impact factor: 2.264

2.  Verification and Defined Dosage of Sodium Pentobarbital for a Urodynamic Study in the Possibility of Survival Experiments in Female Rat.

Authors:  Sheng-Fei Xu; Guang-Hui Du; Kuerbanjiang Abulikim; Peng Cao; Hui-Bing Tan
Journal:  Biomed Res Int       Date:  2020-06-11       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.